Cargando…

Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells

This study reports the therapeutic effectiveness of doxorubicin-conjugated zinc oxide nanoparticles against lung cancer cell line. The zinc oxide nanoparticles (ZnONPs) were first synthesised using a fungus, isolated from air with an extraordinary capability to survive in very high concentrations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Prakriti, Ahmad, Afza, Al-Keridis, Lamya Ahmed, Alshammari, Nawaf, Alabdallah, Nadiyah M., Muzammil, Khursheed, Saeed, Mohd, Ansari, Irfan Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030660/
https://www.ncbi.nlm.nih.gov/pubmed/35458790
http://dx.doi.org/10.3390/molecules27082590
_version_ 1784692196273815552
author Mishra, Prakriti
Ahmad, Afza
Al-Keridis, Lamya Ahmed
Alshammari, Nawaf
Alabdallah, Nadiyah M.
Muzammil, Khursheed
Saeed, Mohd
Ansari, Irfan Ahmad
author_facet Mishra, Prakriti
Ahmad, Afza
Al-Keridis, Lamya Ahmed
Alshammari, Nawaf
Alabdallah, Nadiyah M.
Muzammil, Khursheed
Saeed, Mohd
Ansari, Irfan Ahmad
author_sort Mishra, Prakriti
collection PubMed
description This study reports the therapeutic effectiveness of doxorubicin-conjugated zinc oxide nanoparticles against lung cancer cell line. The zinc oxide nanoparticles (ZnONPs) were first synthesised using a fungus, isolated from air with an extraordinary capability to survive in very high concentrations of zinc salt. Molecular analysis based on 18S rRNA gene sequencing led to its identification as Aspergillus niger with the NCBI accession no. OL636020. The fungus was found to produce ZnONPs via the reduction of zinc ions from zinc sulphate. The ZnONPs were characterised by various biophysical techniques. ZnONPs were further bioconjugated with the anti-cancer drug doxorubicin (DOX), which was further confirmed by different physical techniques. Furthermore, we examined the cytotoxic efficacy of Doxorubicin-bioconjugated-ZnONPs (DOX-ZnONPs) against lung cancer A549 cells in comparison to ZnONPs and DOX alone. The cytotoxicity caused due to ZnONPs, DOX and DOX-ZnONPs in lung cancer A549 cells was assessed by MTT assay. DOX-ZnONPs strongly inhibited the proliferation of A549 with IC50 value of 0.34 μg/mL, which is lower than IC50 of DOX alone (0.56 μg/mL). Moreover, DOX-ZnONPs treated cells also showed increased nuclear condensation, enhanced ROS generation in cytosol and reduced mitochondrial membrane potential. To investigate the induction of apoptosis, caspase-3 activity was measured in all the treated groups. Conclusively, results of our study have established that DOX-ZnONPs have strong therapeutic efficacy to inhibit the growth of lung cancer cells in comparison to DOX alone. Our study also offers substantial evidence for the biogenically synthesised zinc oxide nanoparticle as a promising candidate for a drug delivery system.
format Online
Article
Text
id pubmed-9030660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90306602022-04-23 Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells Mishra, Prakriti Ahmad, Afza Al-Keridis, Lamya Ahmed Alshammari, Nawaf Alabdallah, Nadiyah M. Muzammil, Khursheed Saeed, Mohd Ansari, Irfan Ahmad Molecules Article This study reports the therapeutic effectiveness of doxorubicin-conjugated zinc oxide nanoparticles against lung cancer cell line. The zinc oxide nanoparticles (ZnONPs) were first synthesised using a fungus, isolated from air with an extraordinary capability to survive in very high concentrations of zinc salt. Molecular analysis based on 18S rRNA gene sequencing led to its identification as Aspergillus niger with the NCBI accession no. OL636020. The fungus was found to produce ZnONPs via the reduction of zinc ions from zinc sulphate. The ZnONPs were characterised by various biophysical techniques. ZnONPs were further bioconjugated with the anti-cancer drug doxorubicin (DOX), which was further confirmed by different physical techniques. Furthermore, we examined the cytotoxic efficacy of Doxorubicin-bioconjugated-ZnONPs (DOX-ZnONPs) against lung cancer A549 cells in comparison to ZnONPs and DOX alone. The cytotoxicity caused due to ZnONPs, DOX and DOX-ZnONPs in lung cancer A549 cells was assessed by MTT assay. DOX-ZnONPs strongly inhibited the proliferation of A549 with IC50 value of 0.34 μg/mL, which is lower than IC50 of DOX alone (0.56 μg/mL). Moreover, DOX-ZnONPs treated cells also showed increased nuclear condensation, enhanced ROS generation in cytosol and reduced mitochondrial membrane potential. To investigate the induction of apoptosis, caspase-3 activity was measured in all the treated groups. Conclusively, results of our study have established that DOX-ZnONPs have strong therapeutic efficacy to inhibit the growth of lung cancer cells in comparison to DOX alone. Our study also offers substantial evidence for the biogenically synthesised zinc oxide nanoparticle as a promising candidate for a drug delivery system. MDPI 2022-04-18 /pmc/articles/PMC9030660/ /pubmed/35458790 http://dx.doi.org/10.3390/molecules27082590 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mishra, Prakriti
Ahmad, Afza
Al-Keridis, Lamya Ahmed
Alshammari, Nawaf
Alabdallah, Nadiyah M.
Muzammil, Khursheed
Saeed, Mohd
Ansari, Irfan Ahmad
Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
title Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
title_full Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
title_fullStr Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
title_full_unstemmed Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
title_short Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus Aspergillus niger, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
title_sort doxorubicin-conjugated zinc oxide nanoparticles, biogenically synthesised using a fungus aspergillus niger, exhibit high therapeutic efficacy against lung cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030660/
https://www.ncbi.nlm.nih.gov/pubmed/35458790
http://dx.doi.org/10.3390/molecules27082590
work_keys_str_mv AT mishraprakriti doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT ahmadafza doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT alkeridislamyaahmed doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT alshammarinawaf doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT alabdallahnadiyahm doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT muzammilkhursheed doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT saeedmohd doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells
AT ansariirfanahmad doxorubicinconjugatedzincoxidenanoparticlesbiogenicallysynthesisedusingafungusaspergillusnigerexhibithightherapeuticefficacyagainstlungcancercells